liarozole has been researched along with tetradecanoylphorbol acetate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowden, C; Coene, MC; De Coster, R; End, D; Krekels, M; Van Ginckel, R; Wouters, W | 1 |
1 review(s) available for liarozole and tetradecanoylphorbol acetate
| Article | Year |
|---|---|
Experimental studies with liarozole (R 75,251): an antitumoral agent which inhibits retinoic acid breakdown.
Topics: Animals; Antineoplastic Agents; Cell Division; Humans; Imidazoles; Neoplasms, Experimental; Plasminogen Activators; Testosterone; Tetradecanoylphorbol Acetate; Tretinoin | 1992 |